ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,814.40
-0.85%
S&P ASX All Technology
3,045.20
-2.07%
Brent Oil
83.76
0.67%
US Dollar vs AUD
1.49209
-0.31%
Bitcoin
66,825.94
2.44%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Burning Rock Biotech Ltd (BNR)

  7. Burning Rock Biotech Ltd (BNR) News

BNR

Burning Rock Biotech (BNR)

Burning Rock Biotech Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BNR
DateTimeSourceHeadlineSymbolCompany
14/05/202420:06Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BNRBurning Rock Biotech Ltd
14/05/202416:02GlobeNewswire Inc.Burning Rock Announces ADS Ratio Change to Be Effective on May 15, 2024NASDAQ:BNRBurning Rock Biotech Ltd
29/04/202417:30GlobeNewswire Inc.Burning Rock Publishes 2023 Annual Report on Form 20-FNASDAQ:BNRBurning Rock Biotech Ltd
26/04/202415:59GlobeNewswire Inc.Burning Rock Announces ADS Ratio ChangeNASDAQ:BNRBurning Rock Biotech Ltd
29/03/202408:16GlobeNewswire Inc.Burning Rock Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:BNRBurning Rock Biotech Ltd
15/02/202404:45Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BNRBurning Rock Biotech Ltd
11/01/202408:08Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:BNRBurning Rock Biotech Ltd
04/01/202422:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BNRBurning Rock Biotech Ltd
04/01/202417:03GlobeNewswire Inc.Burning Rock Announces Receipt of Notification from NASDAQNASDAQ:BNRBurning Rock Biotech Ltd
20/12/202322:09Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BNRBurning Rock Biotech Ltd
20/12/202313:35GlobeNewswire Inc.Burning Rock Announces Results of 2023 Annual General MeetingNASDAQ:BNRBurning Rock Biotech Ltd
30/11/202322:08Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BNRBurning Rock Biotech Ltd
30/11/202317:25GlobeNewswire Inc.Burning Rock Reports Third Quarter 2023 Financial ResultsNASDAQ:BNRBurning Rock Biotech Ltd
22/11/202322:08Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BNRBurning Rock Biotech Ltd
22/11/202318:04GlobeNewswire Inc.Burning Rock Announces 2023 Annual General Meeting to be Held on December 20, 2023NASDAQ:BNRBurning Rock Biotech Ltd
21/11/202312:55GlobeNewswire Inc.Burning Rock Schedules Third Quarter of 2023 Earnings Release on November 30, 2023NASDAQ:BNRBurning Rock Biotech Ltd
30/10/202318:20GlobeNewswire Inc.Burning Rock and Boehringer Ingelheim Achieved a Master Service Agreement in Oncology Companion DiagnosticsNASDAQ:BNRBurning Rock Biotech Ltd
16/10/202310:18GlobeNewswire Inc.Burning Rock Received Breakthrough Device Designation from China’s NMPA for its Multi-Cancer Early Detection TestNASDAQ:BNRBurning Rock Biotech Ltd
08/09/202312:43GlobeNewswire Inc.Burning Rock's minimal residual disease (MRD) product supports advancement in early-stage non-small cell lung cancer treatment, with results published in the Cancer CellNASDAQ:BNRBurning Rock Biotech Ltd
05/09/202320:09Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BNRBurning Rock Biotech Ltd
31/08/202315:30GlobeNewswire Inc.Burning Rock Reports Second Quarter 2023 Financial ResultsNASDAQ:BNRBurning Rock Biotech Ltd
04/08/202317:27GlobeNewswire Inc.Burning Rock Provides Second Quarter 2023 Business Updates and Schedules Earnings Release on August 31, 2023NASDAQ:BNRBurning Rock Biotech Ltd
28/06/202318:05GlobeNewswire Inc.Burning Rock Announces Resignation and Appointment of DirectorsNASDAQ:BNRBurning Rock Biotech Ltd
08/06/202314:20GlobeNewswire Inc.Burning Rock's precision oncology diagnostics product supports advancement in late-stage breast cancer treatment, with results published in the New England Journal of MedicineNASDAQ:BNRBurning Rock Biotech Ltd
30/05/202320:18Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BNRBurning Rock Biotech Ltd
30/05/202314:53GlobeNewswire Inc.Burning Rock Reports First Quarter 2023 Financial ResultsNASDAQ:BNRBurning Rock Biotech Ltd
27/04/202315:01GlobeNewswire Inc.Burning Rock Provides First Quarter 2023 Business Updates and Schedules Earnings Release on May 30, 2023NASDAQ:BNRBurning Rock Biotech Ltd
21/04/202312:43GlobeNewswire Inc.Burning Rock Publishes 2022 Annual Report on Form 20-FNASDAQ:BNRBurning Rock Biotech Ltd
21/04/202306:05Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:BNRBurning Rock Biotech Ltd
28/03/202322:32Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BNRBurning Rock Biotech Ltd
 Showing the most relevant articles for your search:NASDAQ:BNR

Your Recent History

LSE
GTL
Gtl Resources
USOTC
ETCK
Enerteck (PK)
NASDAQ
BKUNA
ASX
NABIOA
LSE
72NF
Sigma Fin.3.58%
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved